New hope for myeloma patients: testing a potential alternative treatment
NCT ID NCT07477587
Summary
This study aims to test a new, under-the-skin injection called HLX15-SC for people newly diagnosed with multiple myeloma who are not eligible for a stem cell transplant. Researchers will compare it to an existing approved treatment (DARZALEX FASPRO®) to see if it works similarly in the body and is safe. The goal is to see if this new option can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
American Oncology Network Vista Oncology Division / Physician partner associate
Olympia, Washington, 98506, United States
-
Cancer Specialists of North Florida
Jacksonville, Florida, 32256, United States
-
D&H National Research Center
Margate, Florida, 33063, United States
-
Florida Clinical Trials Group
Plantation, Florida, 33322, United States
-
Florida Clinical Trials Group
Tamarac, Florida, 33321, United States
-
Highlands Oncology Group, PA
Springdale, Arkansas, 72762, United States
-
Oncology Consultants (P1 Trials -Exigent Network)
Houston, Texas, 77030, United States
-
Pontchartrain Cancer Center
Covington, Louisiana, 70433, United States
-
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.